Lipopolysacchride-treated mammary carcinomas secrete proinflammatory chemokines and exhibit reduced growth rates in vivo, but not in vitro.

Nair, P; O'Donnell, C M; Janasek, K; Sajduk, M K; Smith, E A; Golden, J M; Vasta, C A; Huggins, A B; Kurt, Robert A

Nair, P; O'Donnell, C M; Janasek, K; Sajduk, M K; Smith, E A; Golden, J M; Vasta, C A; Huggins, A B; Kurt, Robert A.

Affiliation

Nair P; Department of Biology, Lafayette College, Easton, PA 18042, USA.

Immunol Invest ; 38(8): 730-48, 2009.

Article in En | MEDLINE | ID: mdl-19860585

Subject(s)

Cell Nucleus/metabolism; Chemokines/metabolism; Lipopolysaccharides/pharmacology; Mammary Neoplasms, Animal/metabolism; NF-kappa B/metabolism; Active Transport, Cell Nucleus/drug effects; Animals; Cell Growth Processes/drug effects; Cell Line, Tumor; Chemokines/immunology; Female; Lymphocyte Depletion; Mammary Neoplasms, Animal/drug therapy; Mammary Neoplasms, Animal/immunology; Mammary Neoplasms, Animal/pathology; Mice; Mice, Inbred BALB C; Mice, Nude; Peptidoglycan/pharmacology; Poly I-C/pharmacology; Toll-Like Receptors/agonists

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mammary Neoplasms, Animal / Cell Nucleus / Lipopolysaccharides / NF-kappa B / Chemokines Limits: Animals Language: En Journal: Immunol Invest Journal subject: ALERGIA E IMUNOLOGIA Year: 2009 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google